Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
This trial is active, not recruiting.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Collaborator||University of California, Los Angeles|
|Start date||June 2002|
|End date||September 2003|
|Trial size||20 participants|
|Trial identifier||NCT00040040, NIDA-CTO-0010-1|
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: Please contact site director for more details. Exclusion Criteria: Please contact site director for more details.
|Official title||Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion|
|Principal investigator||Thomas Newton, M.D.|
|Description||This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.|
Call for more information